Reviva Pharmaceuticals Holdings Inc
(NAS:RVPH)
$
2.77
-0.045 (-1.6%)
Market Cap: 94.14 Mil
Enterprise Value: 78.80 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 28/100 Reviva Pharmaceuticals Holdings, Inc. at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 29, 2021 / 05:55PM GMT
Release Date Price:
$4.18
(+0.48%)
Spencer Israel
Benzinga - Moderator
Let me bring up our next speaker here, Laxmina -- no, no, I practiced, and I got it right the first four times, hold on -- Laxminarayan -- did I get that right the second time?
Laxminarayan Bhat
Reviva Pharmaceuticals Holdings, Inc. - Founder, President & CEO
[Thanks, Spencer].
Spencer Israel
Benzinga - Moderator
I just spent the last minute saying it to myself and I still screwed it up. So, I apologize. I'm very sensitive to name pronunciations. Laxminarayan Bhat, he's the founder, President, CEO of the company that's up on the screen, Reviva Pharmaceuticals, ticker RVPH. Do we have your slides from you, sir?
Laxminarayan Bhat
Reviva Pharmaceuticals Holdings, Inc. - Founder, President & CEO
Can you see them now?
Spencer Israel;Laxminarayan Bhat
Benzinga - Moderator;Reviva Pharmaceuticals Holdings, Inc.
Yes, perfect. Thank you. We've got them up.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot